Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-12-26
2006-12-26
Wax, Robert A. (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S380000, C530S381000, C530S382000
Reexamination Certificate
active
07153830
ABSTRACT:
Use of factor XIII for inhibiting the formation of seromas by administering factor XIII. The factor XIII can be administered locally at the site of a wound or surgery or administered systemically. If the factor XIII is administered locally, it can be activated or non-activated and may be administered in conjunction with activated thrombin.
REFERENCES:
patent: 5318524 (1994-06-01), Morse et al.
patent: 5378687 (1995-01-01), Urabe et al.
patent: 5612456 (1997-03-01), Bishop et al.
patent: 6656496 (2003-12-01), Kilpadi et al.
patent: 0268772 (1995-04-01), None
patent: 0236978 (1995-06-01), None
patent: 0691850 (2002-09-01), None
Redacted Research Report.
D'Argenio et al., Dig Dis Sci, 45(5): 987-997 (2000).
Nielsen et al., Cytokines Cell Mol Ther, 3: 267-281 (1997).
Bishop et al., Biochemistry, 29(7): 1861-1869 (1990).
Herouy et al., Lancet, 355: 1970-1971 (2000).
Peschen et al., Vasa, 27(2): 89-93 (1998).
Wozniak et al., Sem. Thromb Hemost, 22(5): 445-450 (1996).
Mishima et al., Chirurg, 55: 803-808 (1984).
Board et al., Blood Rev., 7(4): 229-242 (1993).
Bregenzer et al., Z. Gastroenterol, 37(10): 999-1004 (1999).
Lorenz et al., Sem Throm Hemost, 22(5): 451-455 (1996).
Oshitani et al., Lancet, 347: 119-120 (1996).
Suzuki et al., Blut, 59(2): 162-164 (1989).
Von Bierbrauer et al., Infusiontherapie und Transfusionmedizin, 24: 348-353 (1997).
Utani et al., J Am Acad Dermatol, 24(3): 438-442 (1991).
Kamitsuji et al., Eur J Pediatr, 146(5): 519-523 (1987).
Ichinose et al., Biochemistry, 25(22): 6900-6906 (1986).
Becker et al., Spinal Cord, 39(2): 114-117 (2001).
Isogai et al., Microsurgery, 11: 40-46 (1990).
Weiss et al., J Cell Physiol, 174: 58-65 (1998).
Cairo et al., Scand J Gastroenterol: 485-490 (1999).
Vanscheidt et al., Acta Derm Venereol (Stockh) 71: 55-57 (1991).
Bishop Paul D.
Grossman Angelika
Bork Richard
Green Reza
Smith Len S.
Wax Robert A.
ZymoGenetics Inc.
LandOfFree
Method for inhibiting the formation of seromas using factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting the formation of seromas using factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting the formation of seromas using factor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3710034